Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro

Journal of Cellular Physiology

Volumn 226, Issue 5, 2011, Pages 1196-1203

  Schlegel, Nicolas ^a   Meir, Michael ^a   Spindler, Volker ^a   Germer, Christoph Thomas ^a   Waschke, Jens ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CLAUDIN 1; CYTOTOXIC NECROTIZING FACTOR 1; EXOENZYME C3; LETHAL TOXIN; OCCLUDIN; PROTEIN CDC42; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; TOXIN; TOXIN B; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CELL MEMBRANE PERMEABILITY; ELECTRIC RESISTANCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTESTINAL EPITHELIAL BARRIER; INTESTINE EPITHELIUM; PRIORITY JOURNAL; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; TRANSEPITHELIAL ELECTRICAL RESISTANCE;

ADP RIBOSE TRANSFERASES; AMIDES; BACTERIAL PROTEINS; BACTERIAL TOXINS; BOTULINUM TOXINS; CACO-2 CELLS; CDC42 GTP-BINDING PROTEIN; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENZYME ACTIVATION; ESCHERICHIA COLI PROTEINS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; INTERCELLULAR JUNCTIONS; INTESTINAL MUCOSA; PERMEABILITY; PROTEIN KINASE INHIBITORS; PYRIDINES; RAC1 GTP-BINDING PROTEIN; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; TIME FACTORS;

BACTERIA (MICROORGANISMS);

EID: 79951791225     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22446     Document Type: Article

References (42)

1. Aktories K, Schmidt G, Just I. 2000. Rho GTPases as targets of bacterial protein toxins. Biol Chem 381: 421-426.
2. Artursson P, Ungell A-L, Löfroth J-E. 1993. Selective paracellular permeability in two models of intestinal absorption: Cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm Res 10: 1123-1129.
3. Babbin BA, Sasaki M, Gerner-Schmidt KW, Nusrat A, Klapproth J-MA. 2009. The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating Rho GTPases. Am J Pathol 174: 1347-1357.
4. Baumer Y, Burger S, Curry FE, Golenhofen N, Drenckhahn D, Waschke J. 2008. Differential role of Rho GTPases in endothelial barrier regulation dependent on endothelial cell origin. Histochem Cell Biol 129: 179-191.
5. Baumer Y, Spindler V, Werthmann RC, Bünemann M, Waschke J. 2009. Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J Cell Physiol 220: 716-726.
6. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. 2010. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 103: 40-55.
7. Blumenthal B, Hoffmann C, Aktories K, Backert S, Schmidt G. 2007. The cytotoxic necrotizing factors from Yersinia pseudotuberculosis and from Escherichia coli bind to different cellular receptors but take the same route to the cytosol. Infect Immun 75: 3344-3353.
8. Bruewer M, Hopkins AM, Hobert ME, Nusrat A, Madara JL. 2004. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am J Physiol Cell Physiol 287: C327-C335.
9. Chaturvedi LS, Marsh HM, Shang X, Zheng Y, Basson MD. 2007. Repetitive deformation activates focal adhesion kinase and ERK mitogenic signals in human Caco-2 intestinal epithelial cells through Src and Rac1. J Biol Chem 282: 14-28.
10. Farquhar MG, Palade GE. 1963. Junctional complexes in various epithelia. J Cell Biol 17: 375-412.
11. Fujita H, Katoh H, Hasegawa H, Yasui H, Aoki J, Yamaguchi Y, Negishi M. 2000. Molecular decipherment of Rho effector pathways regulating tight-junction permeability. Biochem J 346: 617-622.
12. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. 2004. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 101: 7618-7623.
13. Gerhard R, Schmidt G, Hofmann F, Aktories K. 1998. Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells. Infect Immun 66: 5125-5131.
14. Halbleib JM, Sääf AM, Brown PO, Nelson WJ. 2007. Transcriptional modulation of genes encoding structural characteristics of differentiating enterocytes during development of a polarized epithelium in vitro. Mol Biol Cell 18: 4261-4278.
15. Hopkins AM, Walsh SV, Verkade P, Boquet P, Nusrat A. 2003. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116: 725-742.
16. Jörgensen VL, Nielsen SL, Espersen K, Perner A. 2006. Increased colorectal permeability in patients with severe sepsis and septic shock. Intensive Care Med 32: 1790-1796.
17. Kapus A, Szszi K. 2006. Coupling between apical and paracellular transport processes. Biochem Cell Biol 84: 870-880.
18. Laukoetter MG, Nava P, Nusrat A. 2008. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 14: 401-407.
19. Nusrat A, Giry M, Turner JR, Colgan SP, Parkos CA, Carnes D, Lemichez E, Boquet P, Madara JL. 1995. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci USA 92: 10629-10633.
20. Papatheodorou P, Zamboglou C, Genisyuerek S, Guttenberg G, Aktories K. 2010. Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS ONE 5: e10673.
21. Rowlands BJ, Soong CV, Gardiner KR. 1999. The gastrointestinal tract as a barrier in sepsis. Br Med Bull 55: 196-211.
22. Samarin S, Nusrat A. 2009. Regulation of epithelial apical junctional complex by Rho family GTPases. Front Biosci 14: 1129-1142.
23. Samarin SN, Ivanov AI, Flatau G, Parkos CA, Nusrat A. 2007. Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell 18: 3429-3439.
24. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21: 1-26.
25. Schlegel N, Waschke J. 2009a. Impaired cAMP and Rac 1 signaling contribute to TNF-alpha-induced endothelial barrier breakdown in microvascular endothelium. Microcirculation 16: 521-533.
26. Schlegel N, Waschke J. 2009b. Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium. J Cell Physiol 220: 357-366.
27. Schlegel N, Waschke J. 2009c. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells. Am J Physiol Cell Physiol 296: C453-C462.
28. Schlegel N, Burger S, Golenhofen N, Walter U, Drenckhahn D, Waschke J. 2008. The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization. Am J Physiol Cell Physiol 294: C178-188.
29. Schlegel N, Baumer Y, Drenckhahn D, Waschke J. 2009. Lipopolysaccharide-induced endothelial barrier breakdown is cAMP dependent in vivo and in vitro. Crit Care Med 37: 1735-1743.
30. Schlegel N, Meir M, Heupel W-M, Holthofer B, Leube RE, Waschke J. 2010. Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 298: G774-G783.
31. Schmidt G, Selzer J, Lerm M, Aktories K. 1998. The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem 273: 13669-13674.
32. Shen L, Turner JR. 2006. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: Tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol 290: G577-G582.
33. Spindler V, Schlegel N, Waschke J. 2010. Role of GTPases in control of microvascular permeability. Cardiovasc Res 87: 243-253.
34. Swank GM, Deitch EA. 1996. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg 20: 411-417.
35. Tsukita S, Furuse M, Itoh M. 2001. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293.
36. +-glucose cotransport. Adv Drug Deliv Rev 41: 265-281.
37. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, Parkos CA, Nusrat A. 2005. Mechanism of IFN-γ-induced endocytosis of tight junction proteins: Myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16: 5040-5052.
38. Walsh SV, Hopkins AM, Chen J, Narumiya S, Parkos CA, Nusrat A. 2001. Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia. Gastroenterology 121: 566-579.
39. Waschke J, Baumgartner W, Adamson RH, Zeng M, Aktories K, Barth H, Wilde C, Curry FE, Drenckhahn D. 2004. Requirement of Rac activity for maintenance of capillary endothelial barrier properties. Am J Physiol Heart Circ Physiol 286: H394-H401.
40. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D. 2006. Inhibition of RhoA activity causes pemphigus skin blistering. J Cell Biol 175: 721-727.
41. Yap AS, Brieher WM, Gumbiner BM. 1997. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 13: 119-146.
42. Yasuda Y, Saito M, Yamamura T, Yaguchi T, Nishizaki T. 2009. Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A(2a) adenosine receptors. J Gastroenterol 44: 56-65.